7Weidekamm E, Portmamn R, Stuter K, et al. Singll-multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans. Agents Chemother, 1987,3(12)1909.
8Blouin RA, Hamecin BA, Smith DA, et al. Fleroxacin pharmacokinetics in patients with liver cirrhosis. Antimicrob Agents Chemother, 1992, 36(3):632.